Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinomaKouya Shiraishi, Takashi Kohno, Shingo Matsumoto et al.|Nature Communications|2016Cited by 58
PD-L1 Expression Is a Prognostic Factor in Patients with Thoracic Esophageal Cancer Treated Without Adjuvant ChemotherapyAkiyuki Wakita, Yoshihiro Minamiya|Anticancer Research|2017Cited by 42
REG Iα PROMOTES PD-L1 EXPRESSION IN ESOPHAGEAL CANCER CELLSAkiyuki Wakita, Yoshihiro Minamiya|Institutional Repositories DataBase (IRDB)|2014Cited by 0